Evidence map›Paper›PMID 31165278›Full record

ArticleJournal of materials science. Materials in medicine2019

In vitro investigation of chemical properties and biocompatibility of neurovascular braided implants.

Giorgio Cattaneo, Chris Bräuner, Gerd Siekmeyer, Andreas Ding, Sabina Bauer, Markus Wohlschlögel, Lisa Lang, Teresa Hierlemann, Maria Akimov, Christian Schlensak and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Giorgio CattaneoAcandis GmbH, Pforzheim, Germany. gcattaneo@acandis.com.
Chris BräunerAdmedes GmbH, Pforzheim, Germany.
Gerd SiekmeyerAcquandas GmbH, Kiel, Germany.
Andreas DingAcandis GmbH, Pforzheim, Germany.
Sabina BauerAcandis GmbH, Pforzheim, Germany.
Markus WohlschlögelAdmedes GmbH, Pforzheim, Germany.
Lisa LangDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.
Teresa HierlemannDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.
Maria AkimovDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.
Christian SchlensakDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.
Andreas SchüßlerAcandis GmbH, Pforzheim, Germany.
Hans-Peter WendelDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.
Stefanie KrajewskiDepartment of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Braiding of Nitinol micro wires is an established technology for the manufacturing of fine-meshed neurovascular implants for tortuous vessel geometries. Electropolishing of wires before the braiding process has the potential to improve the in vitro behaviour in terms of thrombogenicity and endothelial cell proliferation. In this study, we present the first in vitro investigation of braided electropolished/blue oxide Nitinol samples in a blood flow loop, showing a significantly lower activation of the coagulation pathway (represented by the TAT III marker) and a tendency towards reduced platelet adhesion. Furthermore, we applied the same surface treatment on flat disks and measured protein adhesion as well as endothelial cell proliferation. We compared our results to non-electropolished samples with a native oxide surface. While platelet deposition was reduced on electropolished/blue oxide surface, a significant increase of endothelial cell seeding was observed. Investigation of inflammatory marker expression in endothelial cells provided divergent results depending on the marker tested, demanding closer investigation. Surface analysis using Auger electron spectroscopy revealed a thin layer mainly consisting of titanium oxynitride or titanium oxide + titanium nitride as a potential cause of the improved biological performance. Translated to the clinical field of intracranial aneurysm treatment, the improved biocompatibility has the potential to increase both safety (low thrombogenicity) and effectiveness (aneurysm neck reconstruction).

Indexed as

Platelet AdhesivenessProstheses and ImplantsAdsorptionAlloysAneurysmBlood CoagulationBlood PlateletsBlood VesselsCell AdhesionCell ProliferationCoated Materials, BiocompatibleElasticityElectrochemistryEndothelial CellsHumansInflammationAlloysCoated Materials, BiocompatibleNickelnitinolOxidesTitaniumtitanium-nitride-oxide

Identifiers

PMID31165278
PMCPMC7695648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.